Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.40    0.40 (0.62%)
Bid:
65.80
Ask:
66.00
Spread: 0.20 (0.304%)
Market Cap: £577.76m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Form 8.3 - IP Group PLC

Today 15:54

RNS Number : 4449J
Bank of Montreal
23 June 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

BANK OF MONTREAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

IP Group PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

22/06/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

2p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

18,807,614

2.12

0

0.00

(2) Cash-settled derivatives:

 

0

0.00

18,807,614

2.12

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

18,807,614

2.12

18,807,614

2.12

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

23/06/2026

Contact name:

Andrew Manchester

Telephone number*:

020 7862 0823

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEALKDASFKEFA
Date   Source Headline
26th Nov 201911:24 amRNSHolding(s) in Company
25th Nov 20191:59 pmRNSResult of General Meeting
22nd Nov 20195:51 pmRNSHolding(s) in Company
11th Nov 20197:00 amRNSHolding(s) in Company
8th Nov 201912:02 pmRNSNotice of GM
30th Oct 20196:16 pmRNSHolding(s) in Company
28th Oct 20196:06 pmRNSHolding(s) in Company
9th Oct 201910:22 amRNSHolding(s) in Company
8th Oct 20196:08 pmRNSSAYE scheme
2nd Oct 20195:24 pmRNSHolding(s) in Company
2nd Oct 20195:18 pmRNSHolding(s) in Company
27th Sep 20195:58 pmRNSHolding(s) in Company
26th Sep 20195:44 pmRNSHolding(s) in Company
26th Sep 20195:12 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSHalf-yearly results
2nd Sep 201911:48 amRNSHolding(s) in Company
19th Aug 20192:25 pmRNSHolding(s) in Company
13th Aug 20193:31 pmRNSHolding(s) in Company
1st Aug 20194:19 pmRNSHolding(s) in Company
15th Jul 20197:09 amRNSCeres Power signs collaboration with Doosan
15th Jul 20197:00 amRNSIstesso announces positive P2a study of MBS2320
9th Jul 20191:35 pmRNSHolding(s) in Company
9th Jul 201910:50 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSAppointment of Non-executive Director
7th Jun 20195:12 pmRNSHolding(s) in Company
7th Jun 20191:19 pmRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
28th May 20196:04 pmRNSHolding(s) in Company
28th May 20195:42 pmRNSResult of AGM
28th May 201911:13 amRNSAppointment of Caroline Brown as NED
16th May 20196:21 pmRNSWithdrawal of resolution from 2019 AGM
3rd May 20199:38 amRNSAppointment of corporate broker
26th Apr 20196:23 pmRNSLTIP & DBSP awards; DBSP option exercise
18th Apr 20192:54 pmRNSAnnual Financial Report
15th Apr 201911:55 amRNSHolding(s) in Company
11th Apr 20197:12 amRNSDiurnal positive advice from EMA for Chronocort
26th Mar 20197:00 amRNSFinal Results
19th Mar 20193:32 pmRNSHolding(s) in Company
8th Mar 20192:20 pmRNSHolding(s) in Company
5th Mar 20195:54 pmRNSHolding(s) in Company
12th Feb 20199:36 amRNSDirector Declaration
12th Feb 20199:03 amRNSFLF aims for fusion by mid 2019 on Machine 3
28th Jan 20197:00 amRNSPortfolio co Featurespace completes £25m round
18th Jan 20191:25 pmRNSHolding(s) in Company
3rd Jan 20198:56 amRNSHolding(s) in Company
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.